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Acute epiglottitis is most commonly recognised in children as an infection
with H. influenzae and may be a severe and rapidly fatal disease. Less
commonly, adults, compromised by chronic bronchitis, may develop acute
epiglottitis with H. influenzae or with a variety of other organisms including
Streptococcus pneumoniae, Streptococcus pyogenes, Staphylococcus aureus, '
beta -haemolytic group C Streptococci 2 or Klebsiella Spp.3 The peak incidence in
children is 2 -6 years of age, due to the fact that infants receive passive immunity
to H. influenzae in utero which decreases after birth. Susceptibility to infection
then increases until a natural immunity to the micro-organism is developed later
in childhood. There may be a seasonal predominance in the winter months. The
main focus of infection is the supraglottic area, but the acute phase of the
infection is more generalised, producing a state of toxaemia. The presentation is
usually of sudden onset with dyspnoea, stridor, and profuse drooling. The
severity of the infection usually requires immediate medical attention. Prompt
treatment is directed towards relief of any airway obstruction and the eradication
of the aetiological agent by the use of appropriate antibiotics.
PATIENTS
A cluster of four patients with acute epiglottitis presented to the Royal Belfast
Hospital for Sick Children between September and December 1985. Three were
less than 21 months and one was five years of age. Three were female and one
male. All lived within 20 miles of the hospital. They were all previously healthy
and had normal developmental milestones. They presented with sudden onset
of inspiratory stridor, which in two cases followed a reported upper respiratory
tract infection. The diagnosis of acute epiglottitis rather than laryngtracheitis
was suspected due to the severity of presentation. All patients had pyrexia (up
to 40°C), raised leucocyte count (up to 27 x 109/1), and increasing, severe
stridor. One patient had a history of penicillin allergy. Diagnosis was confirmed
clinically at intubation and confirmed microbiologically by the- isolation of
H. influenzae from blood culture. All patients responded to chloramphenicol
within five days with no complications. One patient received ampicillin in addition
to chloramphenicol.
ORGANISMS
The organisms were all isolated from blood cultures using an automated
radiometric blood culture detection system (Bactec) on chocolate blood agar
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in 5-10% C02. Identification was based on X (Haemin) and V (Nicotinamide
Adenine Dinucleotide) growth factor utilisation on nutrient agar. Slide
agglutination (Wellcome Ltd) showed the strains to be Pittman serotype b.
Antibiotic susceptibility testing was by- disc diffusion using the Stokes method4
with the Oxford Staphylococcus NCTC 6571 as control. Minimum inhibitory
concentrations were obtained in broth dilutions ofantibiotics using inocula of 108
colony forming units/litre. Beta-lactamase production was detected using a
chromogenic nitrocefin test.
All the isolates were sensitive to chloramphenicol (10pg disc). Two isolates were
resistant to ampicillin (10pg). In one of these beta-lactamase production was
demonstrated, but the other ampicillin resistant strain was not a beta-lactamase
producer. Both had minimum inhibitory concentrations > 8pg/ml to ampicillin.
DISCUSSION
A. cluster of four cases occurring in a three month period was remarkable as the
frequency of cases brought to the attention of bacteriologists through positive
blood culture is much lower. Most series report an incidence of about one per
thousand paediatric admissions.5 Incidence rates are erratic which may reflect the
cluster-like occurrences over time. There was no reason to suppose that these
cases were epidemiologically related.
Of H. influenzae isolates in Northern Ireland, 9 3% are resistant to ampicillin due
to production of beta- lactamase.6 One of the strains reported was ampicillin
resistant but nota beta- lactamase producer. This form of resistance is uncommon
and is probably due to permeability barriers or structural alterations in penicillin
binding proteins. A much lower incidence of chloramphenicol resistance,
1 7 % has been reported in a United Kingdom survey,7 and this is therefore the
drug of choice in life-threatening H. influenzae infection such as epiglottitis.
Chloramphenicol is also more rapidly bactericidal than ampicillin against
H. influenzae. Indeed even those rare strains producing enzymes which inactivate
chloramphenicol by transacetylation have been successfully treated with high
doses of chloramphenicol.8 High initial doses of 100 mg,/kg/day should be used,
which can be reduced later when quantitative susceptibility tests are available and
a clinical response is shown. Chloramphenicol assays of trough (pre-dose) and
peak (1 hr post dose) serum concentrations should be performed to determine
maintenance intravenous dosage aimed at a peak serum level of 15 -25 mg/I, as
there are large variations in pharmacokinetic responses due to age, liver enzyme
induction, and protein binding displacement. A peak at two hours post dose
should be taken when using oral administration. Marrow toxicity may also be
anticipoted by reticulocyte, haemoglobin, neutrophil, and platelet counts.9 Some
of the newer cephalosporins such as cefuroxime and cefotaxime which show
good in vitro activity against H. influenzae have been used in the treatment of
H. influenzae meningitis and epigolottitis,'0 and provide a suitable therapeutic
alternative to chloramphenicol in epigolottitis without the potential problems of
associated toxicity.
Household contacts under the age of six have a 500 times increased risk of
H. influenzae infection,1' and rifampicin prophylaxis should be considered in this
risk group. Pharyngeal colonisation of contacts is reported to be up to 70%, so
that culture from contacts is not helpful in identifying those at risk. In the United
States of America, familial spread has more commonly been reported and
antibiotic prophylaxis of close contacts is recommended. In this country the
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incidence and rate of spread is much lower and the debate on antibiotic
prophylaxis of contacts has not yet been resolved: there is, however, a reasoned
trend towards antibiotic prophylaxis for close contacts of acute cases.
Bacterial capsular polysaccharide vaccines are now widely used in the United
States of America at 24 months of age, and some studies report significant
reductions in the incidence of H. influenzae type b infection in children over 24
months.'2 Protein polysaccharide conjugate vaccines are being investigated with
the hope of improved protection to include children less than 24 months who are
at greater risk from life-threatening infection.
We wish to thank Professor J Dodge, Dr S Keilty and Dr A Redmond for permission to report these
cases.
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